TP53 and breast cancer: However, in contrast to WT mammary glands, the p53 null mammary epithelium gives rise to hormone-dependent ductal hyperplasia that progress to a heterogeneous group of ERα positive and ERα negative breast cancers with molecular signatures that reflect the luminal, basal and claudin–low subtypes observed in humans [25, 54].